Global Injectable Anticoagulants Market Research Report 2021
Table of Contents1 Injectable Anticoagulants Market Overview
1.1 Product Overview and Scope of Injectable Anticoagulants
1.2 Injectable Anticoagulants Segment by Type
1.2.1 Global Injectable Anticoagulants Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Low-Molecular-Weight Heparin (LMWH)
1.2.3 Direct Thrombin Inhibitor (DTI)
1.2.4 Others
1.3 Injectable Anticoagulants Segment by Application
1.3.1 Injectable Anticoagulants Sales Comparison by Application: (2021-2027)
1.3.2 VTE
1.3.3 ACS/MI
1.3.4 AF
1.3.5 Others
1.4 Global Injectable Anticoagulants Market Size Estimates and Forecasts
1.4.1 Global Injectable Anticoagulants Revenue 2016-2027
1.4.2 Global Injectable Anticoagulants Sales 2016-2027
1.4.3 Injectable Anticoagulants Market Size by Region: 2016 Versus 2021 Versus 2027
2 Injectable Anticoagulants Market Competition by Manufacturers
2.1 Global Injectable Anticoagulants Sales Market Share by Manufacturers (2016-2021)
2.2 Global Injectable Anticoagulants Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Injectable Anticoagulants Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Injectable Anticoagulants Manufacturing Sites, Area Served, Product Type
2.5 Injectable Anticoagulants Market Competitive Situation and Trends
2.5.1 Injectable Anticoagulants Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Injectable Anticoagulants Players Market Share by Revenue
2.5.3 Global Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Injectable Anticoagulants Retrospective Market Scenario by Region
3.1 Global Injectable Anticoagulants Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Injectable Anticoagulants Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Injectable Anticoagulants Market Facts & Figures by Country
3.3.1 North America Injectable Anticoagulants Sales by Country
3.3.2 North America Injectable Anticoagulants Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Injectable Anticoagulants Market Facts & Figures by Country
3.4.1 Europe Injectable Anticoagulants Sales by Country
3.4.2 Europe Injectable Anticoagulants Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Injectable Anticoagulants Market Facts & Figures by Region
3.5.1 Asia Pacific Injectable Anticoagulants Sales by Region
3.5.2 Asia Pacific Injectable Anticoagulants Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Injectable Anticoagulants Market Facts & Figures by Country
3.6.1 Latin America Injectable Anticoagulants Sales by Country
3.6.2 Latin America Injectable Anticoagulants Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Injectable Anticoagulants Market Facts & Figures by Country
3.7.1 Middle East and Africa Injectable Anticoagulants Sales by Country
3.7.2 Middle East and Africa Injectable Anticoagulants Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Injectable Anticoagulants Historic Market Analysis by Type
4.1 Global Injectable Anticoagulants Sales Market Share by Type (2016-2021)
4.2 Global Injectable Anticoagulants Revenue Market Share by Type (2016-2021)
4.3 Global Injectable Anticoagulants Price by Type (2016-2021)
5 Global Injectable Anticoagulants Historic Market Analysis by Application
5.1 Global Injectable Anticoagulants Sales Market Share by Application (2016-2021)
5.2 Global Injectable Anticoagulants Revenue Market Share by Application (2016-2021)
5.3 Global Injectable Anticoagulants Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Sanofi Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 Genentech (Roche)
6.2.1 Genentech (Roche) Corporation Information
6.2.2 Genentech (Roche) Description and Business Overview
6.2.3 Genentech (Roche) Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Genentech (Roche) Product Portfolio
6.2.5 Genentech (Roche) Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Boehringer Ingelheim Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Pfizer
6.4.1 Pfizer Corporation Information
6.4.2 Pfizer Description and Business Overview
6.4.3 Pfizer Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Pfizer Product Portfolio
6.4.5 Pfizer Recent Developments/Updates
6.5 The Medicines Company
6.5.1 The Medicines Company Corporation Information
6.5.2 The Medicines Company Description and Business Overview
6.5.3 The Medicines Company Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
6.5.4 The Medicines Company Product Portfolio
6.5.5 The Medicines Company Recent Developments/Updates
6.6 Aspen
6.6.1 Aspen Corporation Information
6.6.2 Aspen Description and Business Overview
6.6.3 Aspen Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Aspen Product Portfolio
6.6.5 Aspen Recent Developments/Updates
6.7 Otsuka
6.6.1 Otsuka Corporation Information
6.6.2 Otsuka Description and Business Overview
6.6.3 Otsuka Injectable Anticoagulants Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Otsuka Product Portfolio
6.7.5 Otsuka Recent Developments/Updates
7 Injectable Anticoagulants Manufacturing Cost Analysis
7.1 Injectable Anticoagulants Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Injectable Anticoagulants
7.4 Injectable Anticoagulants Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Injectable Anticoagulants Distributors List
8.3 Injectable Anticoagulants Customers
9 Injectable Anticoagulants Market Dynamics
9.1 Injectable Anticoagulants Industry Trends
9.2 Injectable Anticoagulants Growth Drivers
9.3 Injectable Anticoagulants Market Challenges
9.4 Injectable Anticoagulants Market Restraints
10 Global Market Forecast
10.1 Injectable Anticoagulants Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Injectable Anticoagulants by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Injectable Anticoagulants by Type (2022-2027)
10.2 Injectable Anticoagulants Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Injectable Anticoagulants by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Injectable Anticoagulants by Application (2022-2027)
10.3 Injectable Anticoagulants Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Injectable Anticoagulants by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Injectable Anticoagulants by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesTable 1. Global Injectable Anticoagulants Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Injectable Anticoagulants Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Injectable Anticoagulants Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Injectable Anticoagulants Covered in This Study
Table 5. Global Injectable Anticoagulants Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Injectable Anticoagulants Sales Share by Manufacturers (2016-2021)
Table 7. Global Injectable Anticoagulants Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Injectable Anticoagulants Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Injectable Anticoagulants Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Injectable Anticoagulants Manufacturing Sites and Area Served
Table 11. Manufacturers Injectable Anticoagulants Product Type
Table 12. Global Injectable Anticoagulants Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Injectable Anticoagulants by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Injectable Anticoagulants as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Injectable Anticoagulants Sales by Region (2016-2021) & (K Units)
Table 16. Global Injectable Anticoagulants Sales Market Share by Region (2016-2021)
Table 17. Global Injectable Anticoagulants Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Injectable Anticoagulants Sales by Country (2016-2021) & (K Units)
Table 19. North America Injectable Anticoagulants Sales Market Share by Country (2016-2021)
Table 20. North America Injectable Anticoagulants Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Injectable Anticoagulants Revenue Market Share by Country (2016-2021)
Table 22. Europe Injectable Anticoagulants Sales by Country (2016-2021) & (K Units)
Table 23. Europe Injectable Anticoagulants Sales Market Share by Country (2016-2021)
Table 24. Europe Injectable Anticoagulants Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Injectable Anticoagulants Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Injectable Anticoagulants Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Injectable Anticoagulants Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Injectable Anticoagulants Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Injectable Anticoagulants Revenue Market Share by Region (2016-2021)
Table 30. Latin America Injectable Anticoagulants Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Injectable Anticoagulants Sales Market Share by Country (2016-2021)
Table 32. Latin America Injectable Anticoagulants Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Injectable Anticoagulants Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Injectable Anticoagulants Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Injectable Anticoagulants Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Injectable Anticoagulants Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Injectable Anticoagulants Revenue Market Share by Country (2016-2021)
Table 38. Global Injectable Anticoagulants Sales (K Units) by Type (2016-2021)
Table 39. Global Injectable Anticoagulants Sales Market Share by Type (2016-2021)
Table 40. Global Injectable Anticoagulants Revenue (Million US$) by Type (2016-2021)
Table 41. Global Injectable Anticoagulants Revenue Share by Type (2016-2021)
Table 42. Global Injectable Anticoagulants Price (USD/Unit) by Type (2016-2021)
Table 43. Global Injectable Anticoagulants Sales (K Units) by Application (2016-2021)
Table 44. Global Injectable Anticoagulants Sales Market Share by Application (2016-2021)
Table 45. Global Injectable Anticoagulants Revenue (Million US$) by Application (2016-2021)
Table 46. Global Injectable Anticoagulants Revenue Share by Application (2016-2021)
Table 47. Global Injectable Anticoagulants Price (USD/Unit) by Application (2016-2021)
Table 48. Sanofi Corporation Information
Table 49. Sanofi Description and Business Overview
Table 50. Sanofi Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Sanofi Injectable Anticoagulants Product
Table 52. Sanofi Recent Developments/Updates
Table 53. Genentech (Roche) Corporation Information
Table 54. Genentech (Roche) Description and Business Overview
Table 55. Genentech (Roche) Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Genentech (Roche) Injectable Anticoagulants Product
Table 57. Genentech (Roche) Recent Developments/Updates
Table 58. Boehringer Ingelheim Corporation Information
Table 59. Boehringer Ingelheim Description and Business Overview
Table 60. Boehringer Ingelheim Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 61. Boehringer Ingelheim Injectable Anticoagulants Product
Table 62. Boehringer Ingelheim Recent Developments/Updates
Table 63. Pfizer Corporation Information
Table 64. Pfizer Description and Business Overview
Table 65. Pfizer Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 66. Pfizer Injectable Anticoagulants Product
Table 67. Pfizer Recent Developments/Updates
Table 68. The Medicines Company Corporation Information
Table 69. The Medicines Company Description and Business Overview
Table 70. The Medicines Company Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 71. The Medicines Company Injectable Anticoagulants Product
Table 72. The Medicines Company Recent Developments/Updates
Table 73. Aspen Corporation Information
Table 74. Aspen Description and Business Overview
Table 75. Aspen Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 76. Aspen Injectable Anticoagulants Product
Table 77. Aspen Recent Developments/Updates
Table 78. Otsuka Corporation Information
Table 79. Otsuka Description and Business Overview
Table 80. Otsuka Injectable Anticoagulants Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 81. Otsuka Injectable Anticoagulants Product
Table 82. Otsuka Recent Developments/Updates
Table 83. Production Base and Market Concentration Rate of Raw Material
Table 84. Key Suppliers of Raw Materials
Table 85. Injectable Anticoagulants Distributors List
Table 86. Injectable Anticoagulants Customers List
Table 87. Injectable Anticoagulants Market Trends
Table 88. Injectable Anticoagulants Growth Drivers
Table 89. Injectable Anticoagulants Market Restraints
Table 90. Global Injectable Anticoagulants Sales Forecast by Type (2022-2027) & (K Units)
Table 91. Global Injectable Anticoagulants Sales Market Share Forecast by Type (2022-2027)
Table 92. Global Injectable Anticoagulants Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 93. Global Injectable Anticoagulants Revenue Market Share Forecast by Type (2022-2027)
Table 94. Global Injectable Anticoagulants Sales Forecast by Application (2022-2027) & (K Units)
Table 95. Global Injectable Anticoagulants Sales Market Share Forecast by Application (2022-2027)
Table 96. Global Injectable Anticoagulants Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 97. Global Injectable Anticoagulants Revenue Market Share Forecast by Application (2022-2027)
Table 98. Global Injectable Anticoagulants Sales Forecast by Region (2022-2027) & (K Units)
Table 99. Global Injectable Anticoagulants Sales Market Share Forecast by Region (2022-2027)
Table 100. Global Injectable Anticoagulants Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 101. Global Injectable Anticoagulants Revenue Market Share Forecast by Region (2022-2027)
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of FiguresFigure 1. Product Picture of Injectable Anticoagulants
Figure 2. Global Injectable Anticoagulants Market Share by Type in 2020 & 2027
Figure 3. Low-Molecular-Weight Heparin (LMWH) Product Picture
Figure 4. Direct Thrombin Inhibitor (DTI) Product Picture
Figure 5. Others Product Picture
Figure 6. Global Injectable Anticoagulants Market Share by Application in 2020 & 2027
Figure 7. VTE
Figure 8. ACS/MI
Figure 9. AF
Figure 10. Others
Figure 11. Global Injectable Anticoagulants Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Injectable Anticoagulants Market Size 2016-2027 (US$ Million)
Figure 13. Global Injectable Anticoagulants Sales 2016-2027 (K Units)
Figure 14. Global Injectable Anticoagulants Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 15. Injectable Anticoagulants Sales Share by Manufacturers in 2020
Figure 16. Global Injectable Anticoagulants Revenue Share by Manufacturers in 2020
Figure 17. The Global 5 and 10 Largest Injectable Anticoagulants Players: Market Share by Revenue in 2020
Figure 18. Injectable Anticoagulants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 19. Global Injectable Anticoagulants Sales Market Share by Region (2016-2021)
Figure 20. Global Injectable Anticoagulants Sales Market Share by Region in 2020
Figure 21. Global Injectable Anticoagulants Revenue Market Share by Region (2016-2021)
Figure 22. Global Injectable Anticoagulants Revenue Market Share by Region in 2020
Figure 23. U.S. Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Canada Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Germany Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. France Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. U.K. Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Italy Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. Russia Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. China Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Japan Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. South Korea Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. India Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Australia Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Taiwan Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Indonesia Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Thailand Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Malaysia Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Philippines Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Vietnam Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Mexico Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Brazil Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Argentina Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Turkey Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Saudi Arabia Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. U.A.E Injectable Anticoagulants Revenue Growth Rate (2016-2021) (US$ Million)
Figure 47. Sales Market Share of Injectable Anticoagulants by Type (2016-2021)
Figure 48. Sales Market Share of Injectable Anticoagulants by Application (2016-2021)
Figure 49. Sales Market Share of Injectable Anticoagulants by Application in 2020
Figure 50. Revenue Share of Injectable Anticoagulants by Application (2016-2021)
Figure 51. Revenue Share of Injectable Anticoagulants by Application in 2020
Figure 52. Manufacturing Cost Structure of Injectable Anticoagulants
Figure 53. Manufacturing Process Analysis of Injectable Anticoagulants
Figure 54. Injectable Anticoagulants Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed